Press Release: October 10, 2001

WR Hambrecht + Co Initiates Coverage of Cerner Corporation (CERN) with a Buy Rating and $65 Target

San Francisco, CA, October 10, 2001—WR Hambrecht + Co today initiated research coverage on Cerner Corporation (CERN) with a Buy rating and $65 target. WR Hambrecht’s Healthcare Services analyst Sean Wieland cites the company’s marketing deftness and sales growth of its main platform, HNA Millennium, as key reasons for the rating. WR Hambrecht + Co offers all its research reports free and real time at www.wrhambrecht.com.

“If the healthcare services sector can maintain a 40x forward earnings multiple benchmark, which we believe it can, shares of Cerner could trade at $65 within 12 months. We are comfortable with this multiple because it is in-line with the peer group, and within historical averages. Furthermore, the company has an excellent history of strong earnings growth, which we believe is likely to continue,” Wieland said.

WR Hambrecht + Co estimates Cerner to post EPS of $0.89 on revenues of $515.9 million in fiscal 2001 and $1.22 on $599 million in fiscal 2002. Cerner reported an EPS of $0.57 on $404.5 million in fiscal 2000.

Cerner Corporation designs, develops, markets, installs, hosts and supports software information technology and content solutions for healthcare organizations and consumers.